Paola Marcato

Associate Professor

Dalhousie University

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Cancer Biology Cancer Biology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Paola Marcato is an Associate Professor at Dalhousie University in Canada. Her research focuses on cancer biology, specifically within the context of breast cancer and cancer stem cells. Recent articles highlight her work on topics such as the inhibition of angiogenesis, the role of lncRNAs and miRNAs in cancer progression, and the implications of aldehyde dehydrogenase in metastasis. Marcato's contributions are pivotal in advancing therapeutic strategies targeting tumor-promoting pathways and factors.

Articles (17)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (6)

Roseline Godbout

University of Alberta

CANADA

View details

Kirill Rosen

Dalhousie University

CANADA

View details

Graham Dellaire

Professor

Dalhousie University Faculty of Medicine

CANADA

View details

Catherine Too

Professor

Dalhousie University

CANADA

View details

H.P. Vasantha Rupasinghe

Full Professor

Dalhousie University Faculty of Agriculture

CANADA

View details

Melanie R. Power Coombs

Dalhousie University

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paola Marcato

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Phloridzin Docosahexaenoate, an Omega-3 Fatty Acid Ester of a Flavonoid Precursor, Inhibits Angiogenesis by Suppressing Endothelial Cell Proliferation, Migration, and Differentiation

Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways

LncRNAs exhibit subtype-specific expression, survival associations, and cancer-promoting effects in breast cancer

Three-dimensional growth sensitizes breast cancer cells to treatment with ferroptosis-promoting drugs

The Expanding Role of Cancer Stem Cell Marker ALDH1A3 in Cancer and Beyond

ALDH1A3 promotes invasion and metastasis in triple-negative breast cancer by regulating the plasminogen activation pathway.

Breast Cancer Subtype-Specific miRNAs: Networks, Impacts, and the Potential for Intervention

Isolation of cancer stem cells from cultured breast cancer cells and xenografted breast tumors based on aldehyde dehydrogenase activity.

The Prostaglandin E2 Pathway and Breast Cancer Stem Cells: Evidence of Increased Signaling and Potential Targeting.

Metabolite profiling reveals a connection between aldehyde dehydrogenase 1A3 and GABA metabolism in breast cancer metastasis.

LncRNA <i>PART1</i> Promotes Proliferation and Migration, Is Associated with Cancer Stem Cells, and Alters the miRNA Landscape in Triple-Negative Breast Cancer

Triple-Negative Breast Cancer and the COVID-19 Pandemic: Clinical Management Perspectives and Potential Consequences of Infection

An in vivo genome-wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer

Human-specific GAPDH qRT-PCR is an accurate and sensitive method of xenograft metastasis quantification

LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack

Profiling non-small cell lung cancer reveals that PD-L1 is associated with wild type EGFR and vascular invasion, and immunohistochemistry quantification of PDL1 correlates weakly with RT-qPCR

S100A10 Has a Critical Regulatory Function in Mammary Tumor Growth and Metastasis: Insights Using MMTV-PyMT Oncomice and Clinical Patient Sample Analysis

Collaborators (6)

Roseline Godbout

Kirill Rosen

Graham Dellaire

Catherine Too

H.P. Vasantha Rupasinghe

Melanie R. Power Coombs

Make your next move.